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Abstract
Background: Preterm infants are at risk of developing intestinal dysbiosis with an increased proportion of
Gammaproteobacteria. In this study, we sought the clinical determinants of the relative abundance of feces-
associated Gammaproteobacteria in very low birth weight (VLBW) infants. Fecal microbiome was characterized
at ≤ 2 weeks and during the 3rd and 4th weeks after birth, by 16S rRNA amplicon sequencing. Maternal and
infant clinical characteristics were extracted from electronic medical records. Data were analyzed by linear
mixed modeling and linear regression.
Results: Clinical data and fecal microbiome profiles of 45 VLBW infants (gestational age 27.9 ± 2.2 weeks; birth
weight 1126 ± 208 g) were studied. Three stool samples were analyzed for each infant at mean postnatal ages of 9.9 ±
3, 20.7 ± 4.1, and 29.4 ± 4.9 days. The average relative abundance of Gammaproteobacteria was 42.5% (0–90%) at ≤
2 weeks, 69.7% (29.9–86.9%) in the 3rd, and 75.5% (54.5–86%) in the 4th week (p < 0.001). Hierarchical and K-means
clustering identified two distinct subgroups: cluster 1 started with comparatively low abundance that increased with
time, whereas cluster 2 began with a greater abundance at ≤ 2 weeks (p < 0.001) that decreased over time. Both groups
resembled each other by the 3rd week. Single variants of Klebsiella and Staphylococcus described variance in community
structure between clusters and were shared between all infants, suggesting a common, hospital-derived source. Fecal
Gammaproteobacteria was positively associated with vaginal delivery and antenatal steroids.
Conclusions: We detected a dichotomy in gut microbiome assembly in preterm infants: some preterm infants started
with low relative gammaproteobacterial abundance in stool that increased as a function of postnatal age, whereas others
began with and maintained high abundance. Vaginal birth and antenatal steroids were identified as predictors
of Gammaproteobacteria abundance in the early (≤ 2 weeks) and later (3rd and 4th weeks) stool samples, respectively.
These findings are important in understanding the development of the gut microbiome in premature infants.
Keywords: Very low birth weight infant, Gammaproteobacteria, Dysbiosis, Abbreviations, VLBWVery low birth weight,
NECNecrotizing enterocolitis, OTUOperational taxonomic unit
Background
In newborn infants, the enteric microbiome is an
important influence on mucosal immunity, nutrient ab-
sorption, and energy regulation in the developing intes-
tine [1]. Healthy full-term neonates acquire a “core”
enteric microbiome with the inocula received during
and after birth from the maternal microbiota in the
vaginal, fecal, and cutaneous compartments and from
maternal milk [1, 2]. The gut microbiome in these
infants shows dominance of Gram-positive Firmicutes
such as Staphylococcus, Propionibacterium, Bifidobac-
terium, and Lactobacillus [2, 3]. However, in marked
contrast to term infants, preterm infants are at risk of
delayed and altered assembly of their intestinal micro-
biome [4, 5]. These patients have several clinical and
physiological constraints, including absent or limited
exposure to maternal microbiota due to shortened
labor or cesarean birth, mucosal immaturity, and the
lack of physical and immune defenses such as gastric
acid, secretory IgA, and intestinal mucus, frequent
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multisystem organ dysfunction with consequent expos-
ure to broad-spectrum antibiotics and various indwell-
ing tubes and catheters, delays in enteral feeding, and
intestinal dysmotility [3, 5–8]. Many premature infants
show dysbiosis with a preponderance of Gram-negative
bacteria of the class Gammaproteobacteria and its
constituent families Enterobacteriaceae,Vibrionaceae, and
Pseudomonadaceae [9–14]. There are concerns that such
dysbiosis in preterm infants may be associated with
adverse outcomes, including necrotizing enterocolitis,
late-onset sepsis, and developmental delay [5, 10, 11, 15].
In this prospective observational study, we investigated
the clinical antecedents of increased relative abundance
of fecal Gammaproteobacteria in premature infants. Our
goal was to identify the clinical characteristics of pre-
term infants who developed enteral dysbiosis, which in
turn, could inform future efforts to direct microbiome
screening in a clinical setting. We hypothesized that
most premature infants begin with few Gammaproteo-
bacteria in their stool and acquire these bacteria from
the hospital microenvironment or from human inter-
action [16–19], as a function of postnatal age. We rea-
soned that once introduced into the relatively uninhabited
preterm intestine [20], the abundance of gammaproteo-
bacterial taxa would expand with time. Therefore, we
posited that (a) dysbiosis is a stable state wherein fecal
Gammaproteobacteria would either increase in relative
proportion or remain stable, but not decrease over time;
and (b) Gammaproteobacteria-enriched dysbiosis may be
seen in a majority of convalescing premature infants. To
investigate these hypotheses, we recorded the demo-
graphic and clinical information from a cohort of inborn,
very low birth weight (VLBW) infants and analyzed their
fecal microbiome at serial time-points during the first
month after birth.
Methods
Demographic and clinical information
This prospective study was performed after approval by In-
stitutional Review Boards at University of South Florida
and Tampa General Hospital (TGH). We enrolled all eli-
gible VLBW infants admitted to the neonatal intensive care
unit (NICU) at TGH, an academic regional referral center
with a single-patient room floor plan, during the period
May 2012–December 2013. Inclusion criteria included
informed parental consent and the availability of a stool
sample ≤ 2 weeks after birth. Infants with major congenital
anomalies were excluded. The following maternal and neo-
natal information was obtained from medical records:
maternal Hispanic ethnicity, maternal race (Black, White,
Asian, and others), maternal age, duration of ruptured
membranes, clinical chorioamnionitis, maternal hyperten-
sion, diabetes, and her body mass index; antenatal treat-
ment with steroids and magnesium sulfate; mode of
delivery, gestational age, birth weight, postnatal age, post-
menstrual age (gestational age at birth + postnatal age, in
weeks), gender, small-for-gestational age (SGA), singleton/
multiple gestation, Apgar scores, admission temperature,
early-onset or any sepsis (positive blood culture), respira-
tory distress syndrome, surfactant use, need for supple-
mental oxygen and/or positive pressure, patency of the
ductus arteriosus, postnatal treatment with steroids or
indomethacin/ibuprofen, days of antibiotic treatment dur-
ing the first 2 weeks and the total number of days on anti-
biotics during the entire hospital stay, red blood cell
transfusions, feeding (exclusive maternal/donor breast
milk, exclusive formula, and mixed), NEC (Bell stages II
or III [21]), chronic lung disease (need for supplemental
oxygen at 36 weeks’ corrected gestational age), extra-uter-
ine growth restriction, and the length of hospital stay.
Fecal DNA amplification
Stool samples obtained at ≤ 2 weeks, the 3rd week, and
the 4th week after birth were stored at − 80°C under uni-
form conditions until analysis [22]. Total DNA from 100
to 250 mg stool (MoBio PowerFecal DNA kit, Qiagen,
Carlsbad, CA) was used to amplify the V4 region of 16S
rRNA gene using polymerase chain reaction with modi-
fied 515F and 806R primers [23, 24]. These DNA seg-
ments were sequenced using the MiSeq platform
(Illumina, San Diego, CA) to generate about 15,000,250
base-pair paired-end reads per sample [24].
Statistical analysis
Demultiplexed DNA sequences were analyzed for bac-
terial identification to genus level using the CLC Bio-
medical Workbench 3.5.3 (Qiagen) using the default
setting. Operational taxonomic units (OTUs) were
assigned based on 97% sequence identity to the Green-
genes v13.8 reference database, and their relative abun-
dance (percentage) was computed. Bacterial diversity
was measured within samples (alpha-diversity) as the
number of OTUs, phylodiversity, and the Chao 1, Simp-
son, and Shannon indices; between samples (beta-diver-
sity) by principal coordinate analysis and permutational
multivariate analysis of variance (PERMANOVA) of
weighted and unweighted UniFrac distance matrices,
Jaccard coefficient, and the Bray-Curtis dissimilarity
index. To improve upon the taxonomic resolution of the
microbial analysis, we characterized OTUs to single nu-
cleotide variants (SNVs) using Divisive Amplicon
De-noising Algorithm 2 (DADA2) [25]. The V4 region
16S rRNA gene amplicon data was analyzed using the
DADA2 pipeline. First, the demultiplexed fastq files were
filtered and trimmed. Each sample was dereplicated, a
portion of the data set was used to estimate the error pa-
rameters, and dada() was applied to the full pooled data
set using those inferred error parameters. Paired reads
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were then merged, and removeBimeraDenovo() was used
to remove chimeras. Taxonomy was assigned against the
Greengenes v13.8 database (see Additional file 1 for
Code for DADA2). Volatility analysis was performed by
comparing unweighted UniFrac distances on SNVs
between subgroups. To identify the predictive value of
subgroups on microbiome community composition, we
applied random forest machine learning (after rarefying
to 5000 sequences/sample, 1000 trees) and Analysis of
Composition of Microbiomes (ANCOM) [26]. Finally, to
determine whether the data on relative abundance/pro-
portions reflect a change in the absolute abundance of
specific taxa, we performed Balance Tree Analysis using
Gneiss [27].
Clinical information was analyzed using SPSS (IBM,
Armonk, NY). Scalar variables were compared by the
Mann-Whitney U [28] or Student’s t test [29], and
categorical variables by Fisher’s exact test [30]. We used the
linear mixed-effects modeling procedure [31] to identify
determinants of fecal bacterial colonization. The linear
mixed-effects procedure was performed using the max-
imum likelihood method. The autoregressive covariance
matrix (with heterogeneous variances) was used as the
dependent variables were anticipated to diverge with time.
Best-fitting models were identified for lowest values of the
− 2 log likelihood, Akaike’s information criterion, and
Schwarz’s Bayesian criterion [32]. Important independent
variables were shortlisted using bootstrap bagging [33],
where a bootstrap dataset was constructed by not sampling
a third of all subjects and replacing these by an equal num-
ber of duplicated samples. The bootstrap sample was ana-
lyzed by logistic regression with entry criterion of p < 0.2.
The number of times a risk factor appeared in these 1000
analyses was taken as a reflection of the reliability. Because
of the limited number of subjects in the study cohort and
concern about model overfitting, multivariable analyses
were limited to biologically plausible associations, to main
effects for baseline measures, and time-dependent covari-
ates for longitudinal measures. Models were adjusted for
birth weight, gestation, and postmenstrual age. To ensure
stability/reliability of estimates, 95% confidence intervals
(CI) were re-estimated by bootstrapping (n = 1000). We
also performed linear regression to identify the determi-
nants of gammaproteobacterial abundance at each time-
point of stool collection. Variables identified for the
mixed-effects analysis were tested with entry at p < 0.2
and acceptance at p < 0.05, first using a one-step forced
entry and then “stepwise” in the sequence of appearance
during perinatal period [34]. To identify highly correlated
variables, multicollinearity diagnostics (tolerance values <
0.2, variance inflation factors > 10) were reviewed [35].
The independence of variables was confirmed by the
Durbin-Watson statistic (models accepted if between 1.5
and 2.5) [36]. Scatterplots of standardized residuals vs.
standardized predicted values were evaluated for homo-
scedasticity and nonlinearity. Normality of residuals was
confirmed by evaluation of histograms and normal prob-
ability plots. Statistical tests were two-tailed and consid-
ered significant at p < 0.05.
Results
Demographic and clinical information
We enrolled 45 eligible VLBW infants admitted to our
NICU between May 2012 and December 2013. These
infants were born at a gestation (mean ± standard deviation,
Table 1 Perinatal and neonatal clinical characteristics
Characteristic N = 45
Gestational age, weeks, (mean, SD) 28 (2)
Birth weight, grams, (mean, SD) 1126 (208)
Male 21 (46.7%)







Vaginal birth 11 (24.4%)
Multiple birth 7 (15.6%)
Chorioamnionitis 26 (47.8%)
Maternal hypertension 13 (28.9%)
Small for gestational age 3 (6.7%)
Respiratory distress syndrome 26 (57.8%)
Oxygen on day 28 11 (24.4%)
Oxygen on day 36 2 (4.4%)
Patent ductus arteriosus 6 (13.3%)
Indomethacin 2 (4.4%)
Patent ductus arteriosus ligation 1 (2.2%)
Treated retinopathy of prematurity 0
Necrotizing enterocolitis 1 (2.2%)
Surgical necrotizing enterocolitis 1 (2.2%)
Days on antibiotics, (mean, SD) 4.5 (4.7)
Positive blood culture 5 (11.1%)
Packed red blood cell transfusion 16 (35.6%)
Feeding type
Maternal breast milk only 25 (55.6%)
Formula only 2 (4.4%)
Mixed feeding types 18 (40.0%)
Discharge weight < 10th percentile 11 (24.4%)
Length of stay, days, (mean, SD) 68 (29)
Ho et al. Microbiome  (2018) 6:157 Page 3 of 13
SD) of 27.9 ± 2.2 weeks, with birth weight 1126 ± 208 g.
Their clinical characteristics are summarized in Table 1.
Fecal microbiome
Three stool samples were analyzed from all infants,
obtained at the postnatal age (mean ± SD) 9.9 ± 3, 20.7 ±
4.1, and 29.4 ± 4.9 days, respectively. The postmenstrual
age at these time-points was 29.8 ± 2.3, 31.2 ± 1.9, and
32.6 ± 1.9 weeks, respectively. A total of 2,017,727 reads
was obtained, with a mean 15,285 (± standard deviation
7139) sequences per sample. One of the stool samples at
the first time-point had inadequate biomass for DNA
sequencing and was excluded. The alpha-diversity metrics
(number of OTUs, phylodiversity, and Shannon, Chao1,
and Simpson indices) increased with postnatal age (see
Additional file 2: Table S1).
Major bacterial communities in stool
Proteobacteria increased in abundance over time, com-
prising 46% (median; interquartile range/IQR = 0–90%) of
all reads at ≤ 2 weeks, 83.5% (54.8–93.3%) in the 3rd and
77% (57–88.3%) in the 4th week (p < 0.001). The class
Gammaproteobacteria dominated the Proteobacteria,
comprising 42.5% (0–90%) at ≤ 2 weeks, 69.7% (29.9–
86.9%) in the 3rd, and 75.5% (54.5–86%) in the 4th
week (p < 0.001) (Fig. 1, Additional file 2: Table S2).
Fig. 1 Relative abundance of major bacterial taxonomic units in stool over time. Line diagrams (means ± standard deviation) show the relative
abundances of major bacterial taxonomic units in stool, by cluster. Stool samples were collected during the first 2 weeks, and then during the 3rd
and the 4th weeks, respectively. Repeated measures analysis of variance; *p < 0.05, **p < 0.01, and ***p < 0.001
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Gammaproteobacteria comprised > 50% reads in 20/44
(45.5%) infants at ≤ 2 weeks, 29/45 (64.4%) in the 3rd
week, and 36/45 (80%) in the 4th week. Klebsiella
were the predominant gammaproteobacterial genus,
dominating nearly all infants (median 44%, range 0–
100% at ≤ 2 weeks, 85% (0–99%) in the 3rd, and
78.5% (0–99%) in the 4th week (changes not signifi-
cant because of high inter-infant variability). A SNV
mapping to Klebsiella comprised 0.18% of all reads
(median, range 0–99.4%) at ≤ 2 weeks, 24.6% (0–
99.5%) in the 3rd (p = 0.034), and 26.2% (0–99.4%) in
the 4th week (not significant vs. ≤ 2 week samples).
Identified gammaproteobacterial genera are listed in
Additional file 2: Table S3.
Firmicutes were the second most abundant phylum at
≤ 2 weeks (median 41.5%, IQR 3.25–100%). The class
Bacilli accounted for nearly all Firmicutes at ≤ 2 weeks
(100%, IQR 60–100%), whereas Clostridia were dominant
during the 4th week (42%, IQR 8.5–85%; p < 0.001). At the
genus level, Staphylococcus were abundant at ≤ 2 weeks
and decreased with age, whereas Enterococcus increased
over time. Lactobacillus were scant. Other Firmicute genera
are presented in Additional file 2: Table S4. Actinobacteria
and Bacteroidetes were nearly absent from this cohort (see
Additional file 2: Table S2).
Cluster analysis for fecal abundance of Gammaproteobacteria
The relative abundance of Gammaproteobacteria in ≤
2 week samples varied widely (0–90%; see Additional file 2:
Table S2). Therefore, we looked for evidence of clustering
in our cohort. Hierarchical and K-means clustering [37] of
Gammaproteobacteria percentages in the 44 first time-point
stool samples showed 2 subgroups (Fig. 2a, b): cluster 1 (20
infants) started with low gammaproteobacterial abundance
(mean ± SD 2.09 ± 5.91%, median 0, range 0–25%), whereas
cluster 2 (24 infants) showed greater gammaproteobacterial
relative abundance (mean ± SD 79.18 ± 21.6%, median
84.5%, range 31.36–99%; p < 0.001). Cluster 1 infants had
lower birth weight (mean ± SD 1053 ± 227 g vs. 1176 ±
175 g in cluster 2; p = 0.049) and were less likely to have
had a vaginal birth (1/20 in cluster 1 vs. 10/24 in cluster 2,
p= 0.006). Their clinical characteristics are summarized in
Additional file 2: Table S5, and the OTUs in Additional file 2:
Table S6 a–c. Multiple birth participants sorted to the same
cluster as their siblings, indicating the validity of this group-
ing. Random forest analysis predicted cluster identity with a
prediction/error ratio of 2.2, but did not identify any SNVs
with a large feature importance score (see Additional file 2:
Table S7).
Cluster 1 gained Gammaproteobacteria over time
(p < 0.001, 3rd and 4th weeks compared to ≤ 2 week
samples), whereas cluster 2 showed a transient drop
in Gammaproteobacteria in the 3rd week before a
4th week rebound (p = 0.042; Fig. 3; in Add-
itional file 2: Table S6 a–c). In cluster 2, Klebsiella
was the most abundant genus (median 96%, range
0–99%; detected in 19/24 infants), and one particular
SNV was dominant (60.8%, 0–99.4%). During the 3rd
and the 4th weeks, both clusters showed increasing
alpha-diversity and comparable Gammaproteobacteria
relative abundance (Additional file 2: Tables S6b, c
and S8a, b). Beta-diversity comparisons showed
greater between-sample diversity in cluster 2 at ≤
2 weeks, but these differences narrowed over time
(Additional file 2: Table S8c). Volatility analysis
confirmed a significant difference in variability in
A B
Fig. 2 Clustering of VLBW infants by the relative abundance of fecal Gammaproteobacteria. a Dendrogram shows the average linkage (between
the two groups) derived by hierarchical clustering. b. Scatter-plot shows that the VLBW infants included in our study were grouped into two distinct
clusters based on the relative abundance of Gammaproteobacteria (percentages) in stool samples obtained during the first two postnatal weeks
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unweighted UniFrac distances between the clusters
(p = 0.038; Fig. 4) (Additional file 3).
ANCOM was performed to identify single nucleotide
variant (SNV) sequences that described the variance in
the microbiome community differences between clusters
1 and 2. A single variant of Klebsiella and a variant of
Staphylococcus showed significantly different relative
abundance between the two clusters (p < 0.05; after false
discovery rate correction). This same Staphylococcus
SNV also had a significantly different relative abundance
between the three time-points (p < 0.001) and decreased
over time. No SNVs were significantly different between
individual infants. The heat map of the most abundant
SNVs in the cohort is shown in Fig. 5.
Data on relative abundance/proportions does not in-
form whether specific taxa have grown or decreased in
absolute abundance. We performed Balance Tree ana-
lysis, which uses the concept of balances to account for
the compositional nature of 16S rRNA data. We calcu-
lated a bifurcating tree relating the DADA2 sequence
variants to each other by time-point (stool number) to
determine if certain sequence variants appeared only in
early or late stages. We then performed linear regression
by cluster membership, which confirmed that cluster 2
showed increased Klebsiella (Fig. 6).
Clinical antecedents of fecal colonization with
Gammaproteobacteria
We performed mixed-effects modeling to identify the
clinical determinants of the relative abundance of fecal
Gammaproteobacteria. Small-for-gestational age (SGA),
ethnicity, vaginal birth, antenatal steroids, magnesium
Fig. 3 Relative abundance of major bacterial taxonomic units in stool, by cluster. Line diagrams (means ± standard deviation) show the relative
abundances of major bacterial taxonomic units in stool in clusters 1 and 2. Stool samples were collected during the first 2 weeks, and then during the
3rd and the 4th weeks, respectively. Repeated measures analysis of variance; *p < 0.05, **p < 0.01, and ***p < 0.001
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sulfate, chorioamnionitis, gender, multiple births, postna-
tal age, enteral feedings, RDS, PDA, sepsis, and transfu-
sions were defined as fixed effects. Maternal BMI, birth
weight, gestation, postmenstrual age at stool collection,
duration of ruptured membranes, antibiotic treatment, and
the total length of hospital stay were defined as random ef-
fects. The best-fitting, parsimonious model (Table 2)
showed positive associations of fecal Gammaproteobacteria
with vaginal birth (F = 9.55, p = 0.002) and antenatal ste-
roids (F = 4.23, p = 0.042). There was also a borderline,
negative effect of maternal magnesium sulfate therapy (F =
3.87, p = 0.051). There was no effect of gestational or post-
menstrual age. When we used Klebsiella as the dependent
variable, the associations with vaginal birth (F = 10.91, p =
0.001) and antenatal steroids (F = 7.29, p = 0.008)
remained consistent.
We next performed linear regression to identify the
determinants of Gammaproteobacteria relative abundance
at the three time-points of stool collection. At ≤ 2 weeks,
Gammaproteobacteria abundance was associated with
vaginal birth, Latino ethnicity, postnatal age, and the num-
ber of antibiotic days (r2 = 0.69, F = 5.66, p < 0.001; see
Additional file 2: Table S13). When individual antibiotics
were included, gentamicin (b = 15.03, SE 5.35, p = 0.009),
but not ampicillin, showed a significant effect. The
regression models were less robust during the 3rd week
(r2 = 0.34, F = 3.02, p = 0.026), but postnatal age and
antenatal steroids continued to show significant effects
Fig. 4 Volatility analysis of the two clusters: Histogram shows the distribution of unweighted UniFrac distances between successive time-points. A
distance of 1 means maximally different communities, while a distance of 0 implies identical communities, so a curve shifted toward 0 means lower
variability between successive time-points. The two clusters showed a significant difference in variability (p = 0.038)
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(see Additional file 2: Table S14). The 4th-week regres-
sion models were a better fit (r2 = 0.68, F = 4.26, p = 0.001)
and showed positive effects of postnatal age, antenatal
steroids, respiratory distress syndrome (RDS), and red cell
transfusions, and negative effects of magnesium sulfate,
admission temperature, and total antibiotic days. Individual
antibiotics did not show a significant effect. There
was a borderline, positive effect of human milk feed-
ings (p = 0.055; see Additional file 2: Table S15).
In cluster 1, mixed modeling showed increased Gam-
maproteobacteria with postnatal age (p = 0.002). Cluster
2 showed increased Gammaproteobacteria with vaginal
birth (p = 0.019) and antenatal steroids (p = 0.001), and
negative associations with small-for-gestational-age sta-
tus (SGA) (p < 0.001), Latino ethnicity (p = 0.009), and
chorioamnionitis (p = 0.016; Tables 3 and 4). Regression
analysis in cluster 1 at ≤ 2 weeks (r2 = 0.87, F = 8.88, p
= 0.004) showed increased Gammaproteobacteria with
human milk feedings. In cluster 2, patent ductus
arteriosus (PDA) had a negative effect (Additional file 2:
Table S9a, b).
Clinical determinants of the relative proportions of other
bacterial phyla
Fecal Firmicutes were positively associated with cesarean
birth (F = 21.49, p < 0.001) and negatively with postnatal
age (F = 5.08, p = 0.026). We attempted, but did not find
evidence of clear clustering of subjects based on the
relative abundance of Firmicutes, Bacilli, or Clostridia.
Comparison of clusters based on Gammaproteobacteria
abundance (as described in preceding sections) showed
interesting differences in the relative abundance of Fir-
micutes. Cluster 1 carried more Firmicutes and Bacilli
than cluster 2 in the earliest (≤ 2 weeks) and 3rd week
stool samples (Additional file 2: Table 6a–c and S10a).
In cluster 1, Firmicutes were associated positively with
Latino ethnicity and negatively with postnatal age
(Additional file 2: Table S10b). Bacilli decreased with
Fig. 5 Heat map of the most abundant single nucleotide variants (SNVs): Heat map shows the relative abundance of the 18 most abundant SNVs
at each sample. The bar at the top is color coded according to time-point. Blue = most abundant, yellow = least abundant (minimum abundance
displayed = 0.165% mean abundance across samples)
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postnatal age in cluster 2 (Fig. 5 and Additional file 2:
Table S11a–c). Staphylococcus was dominant in cluster
1 at ≤ 2 weeks (median 100%, range 2–100%; detected
in all infants). Most mapped to one particular SNV
(median abundance 98% of all Staphylococcus, range
1.8–100%), which was confirmed in Balance Tree
analysis (Fig. 6). Clostridia increased with postnatal
age (F = 8.81, p = 0.004), particularly in cluster 2
(Additional file 2: Table S12a–c).
Discussion
We present a detailed analysis of the clinical determi-
nants of the proportion of Gammaproteobacteria in the
stool of preterm infants. Consistent with our hypoth-
esis, the overall proportion of Gammaproteobacteria
increased in stool with postnatal age. However, we
noted two distinct patterns: one group started with a
low relative abundance of Gammaproteobacteria in
early stool samples (≤ 2 weeks) that increased with
time, whereas a second group of infants started with
a high relative abundance of Gammaproteobacteria
that dipped transiently during the 3rd week. By the
4th week, the two groups had similar levels of Gam-
maproteobacteria. To our knowledge, this is the first
study to describe this dichotomy in gut microbiome
assembly in premature infants.
Fig. 6 Balance tree analysis for major bacterial taxa. Bifurcating tree relating the DADA2 sequence variants to each other by the time-point for
stool collection highlights specific sequence variants that appeared only in early or late stages. Linear regression by cluster membership confirmed
increased Klebsiella in cluster 2. Cluster 1 showed a true increase in Staphylococcus sequence variant
Table 2 Linear mixed-effects model for the relative fecal abundance of Gammaproteobacteria
Parameter Estimate Std. error p value 95% CI Bootstrapping 95% CI
Lower Upper Lower Upper
Intercept 24.06 22.35 0.284 − 20.19 68.32 − 21.98 345.46
Absence of SGA status 1.90 13.28 0.887 − 24.40 28.19 − 72.52 23.13
Cesarean birth − 23.63 7.65 0.002 − 38.77 − 8.49 − 40.33 − 4.88
Absence of Latino ethnicity 6.86 7.67 0.373 − 8.32 22.04 − 7.73 32.45
Absence of antenatal steroids − 23.57 11.47 0.042 − 46.28 − 0.87 − 46.27 14.82
Absence of antenatal magnesium
sulfate therapy
15.38 7.81 0.051 − 0.09 30.85 − 12.83 33.13
Absence of chorioamnionitis 8.41 6.70 0.212 − 4.85 21.67 − 7.79 25.40
Time 2.71 1.70 0.115 − 0.67 6.08 − 7.67 6.17
* Significant p-values (<0.05) are shown in italics
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The development of the preterm gut microbiome is an
area of intense scientific scrutiny. Currently, there are two
conceptual models: in the first [38], the microbiome is be-
lieved to develop in a non-random, patterned progression
where host maturation is important and environmental
factors have only a minimal, non-enduring influence on
the gut microbiome. In the 2nd model, the environment is
key: factors such as the hospital microflora, diet, and anti-
biotics are believed to fundamentally alter gut microbiome
assembly [2, 39–42]. Our findings suggest that both
models have merit. Cluster 1 showed the sequential dom-
inance of Bacilli, Gammaproteobacteria, and Clostridia in
stool samples collected during the first 2, the 3rd, and the
4th weeks, respectively. These findings were consistent with
those of La Rosa et al. [38], except that we did not find
effects of gestational or postmenstrual age. These infants
began life with a low relative abundance of Gammaproteo-
bacteria but showed greater variability between time-
points in our volatility analysis. The low alpha-diversity
and high beta-diversity in cluster 1 may be interpreted
as a gammaproteobacterial bloom during their NICU
stay that transiently crowded out other members of a
microbial community. These findings differ from those
in cluster 2, who showed high relative abundance of
fecal Gammaproteobacteria from the earliest stool sam-
ple. The identification of vaginal birth as the leading
determinant of stool-associated Gammaproteobacteria
in this group suggests that vertical, mother-to-infant trans-
mission of Gammaproteobacteria may contribute to intes-
tinal dysbiosis in some preterm infants. This information is
important for clinical practice improvement and infection
control measures. In preterm infants, early colonization
with Gammaproteobacteria has been generally associated
with horizontal transmission of these bacteria in the NICU
and selection pressures from antibiotics and diet. How-
ever, the possibility of vertical transmission in some
infants is novel and indicates a need for additional pre-
ventive strategies starting before and during birth.
The dominance of a single variant of Klebsiella in
cluster 2 infants indicates a common, possibly hospital-
derived, source. Women with high-risk pregnancies are
often exposed repeatedly to the hospital environment
while being monitored/treated for pregnancy complica-
tions and are at risk of becoming colonized with hospital
microflora. In our cohort, 25/43 (58%) mothers had
received inpatient care for ≥ 3 hospital days and 22/43
(51%) had ≥ 2 hospital visits before delivery, mostly for
actual or imminent preterm labor. We speculate that
Table 3 Linear mixed-effects model for the relative fecal abundance of Gammaproteobacteria in cluster 1
Parameter Estimate Std. error p value 95% CI
Lower Upper
Intercept − 71.41 44.94 0.118 − 161.47 18.65
Absence of SGA status − 14.95 30.96 0.631 − 76.99 47.08
Cesarean birth 3.24 21.84 0.883 − 40.53 47.00
Absence of Latino ethnicity 34.19 10.82 0.003 12.50 55.89
Absence of antenatal steroids − 20.38 17.39 0.246 − 55.24 14.47
Absence of antenatal magnesium
sulfate therapy
4.56 16.41 0.782 − 28.34 37.45
Absence of chorioamnionitis 5.18 8.50 0.545 − 11.85 22.20
Postnatal age 7.25 2.23 0.002 2.78 11.72
* Significant p-values (<0.05) are shown in italics
Table 4 Linear mixed-effects model for the relative fecal abundance of Gammaproteobacteria in cluster 2
Parameter Estimate Std. error p value 95% CI
Lower Upper
Intercept 885.64 111.30 0.000 667.49 1103.78
Absence of SGA status − 123.76 20.12 0.000 − 163.21 − 84.31
Cesarean birth − 18.48 7.89 0.019 − 33.95 − 3.02
Absence of Latino ethnicity 29.33 11.18 0.009 7.36 51.29
Absence of antenatal steroids − 51.94 14.89 0.001 − 81.17 − 22.71
Absence of antenatal magnesium
sulfate therapy
− 1.12 8.05 0.889 − 17.09 14.84
Absence of chorioamnionitis 22.26 9.26 0.016 4.09 40.43
Postnatal age − 7.76 1.74 0.000 − 11.17 − 4.35
* Significant p-values (<0.05) are shown in italics
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cluster 2 infants, who were more likely to have had a vagi-
nal birth, may have received a larger inoculum of Gamma-
proteobacteria/Klebsiella than cluster 1 because of the
exposure to maternal microflora in the vaginal, fecal, and
cutaneous compartments. We are unable to investigate
these possibilities further as we did not collect maternal
and hospital environmental samples in the present study.
During pregnancy, the vaginal microbiome is dominated by
Firmicutes [43, 44]. In women with vaginal dysbiosis,
pathobionts such as Prevotella, Sneathia, Atopobium,
Mycoplasma, and Gardnerella can be identified [43, 44],
but Gammaproteobacteria are infrequent [45]. The putative
microbiome of the placenta and the amniotic fluid includes
Gammaproteobacteria [46] and could be a plausible source,
but this should affect all infants, regardless of delivery
mode. Other potential sources may include exposure to
maternal enteric flora during vaginal birth and then to the
microbiome of human milk, both of which contain Gam-
maproteobacteria and often Klebsiella in particular [47, 48].
The identification of postnatal age as a determinant of
Gammaproteobacteria abundance was consistent with
the acquisition of these bacteria from care providers and
the hospital environment. However, the transient drop
in fecal Gammaproteobacteria we observed in cluster 2
infants during the 3rd postnatal week was contrary to
our hypothesis that once established in the relatively
uninhabited preterm intestine [49], Gammaproteobac-
teria would either increase or remain stable, but not
decrease, over time. These findings need to be con-
firmed with quantitative measurements of Gammapro-
teobacteria abundance, but if validated, would have
important implications for evaluating dysbiosis as a pre-
dictor of adverse outcomes in VLBW infants [11] as the
best timing for measuring Gammaproteobacteria abun-
dance will need to be ascertained.
The association of Latino ethnicity with fecal Gamma-
proteobacteria may be rooted in genetic factors [50],
although there may have been a confounding influence of
the type of feedings: 8/9 (88.8%) Latino infants received
only human milk vs. 17/36 (47.2%) infants of other ethnic
groups (p = 0.03). The association of fecal Gammaproteo-
bacteria with antenatal steroids, magnesium sulfate, and
the admission temperature is also not easily explained.
Interestingly, the effect of antenatal steroids was delayed,
seen only in the later stool samples (from the 3rd and 4th
weeks). Steroids could alter the host-microbial cross-talk
by dampening leukocyte activation and cytokine expres-
sion [51–54] or via epigenetic changes in the mucosa [55].
Perinatal exposure to magnesium sulfate alters gut motil-
ity and some immune responses [56, 57], but the effects
on fecal microbiome need further study. Human milk
feedings increased fecal Gammaproteobacteria at ≤ 2 weeks,
but had a negative effect later. The early effects may
be related to milk-borne Gammaproteobacteria [47],
possibly selected under the influence of other factors
such as antibiotics. Later, negative effects may reflect
the benefits of milk prebiotics [58], but the high
prevalence of dysbiosis in our cohort indicates that
such protection, at least in hospitalized infants, may
be modest. Antibiotics, and gentamicin in particular,
were associated with increased Gammaproteobacteria
during the early neonatal period, but in the 4th week,
antibiotic days had a negative effect. Antibiotics do
create an environment that promotes the abundance
of Gammaproteobacteria [59], but it is unclear why
these effects should change with postnatal age.
The strengths of our study are its prospective design,
availability of clinical and laboratory data, and repeated
measurements of the gut microbiome. The dataset comes
from a NICU with a single-patient room floor plan, which
is now the favored NICU design and should be represen-
tative of most centers in the USA. Emerging data indicate
that the floor plan (patient pods vs. single-patient rooms)
may be an important determinant of horizontal microbial
spread in the NICU [60]. Our study is constrained by its
limited sample size and single study site. In addition, the
low incidence of NEC in our cohort is a limitation that
prevented us from using NEC as a measured outcome.
Our findings of high Gammaproteobacteria abundance in
some infants within the first 2 weeks also indicate an op-
portunity to confirm these findings in meconium, which
should contain the original, “at birth” microbiome. Finally,
the detection of dysbiosis with predominance of a few bac-
terial communities does not imply pathogenicity, but
needs further evaluation at higher levels of resolution.
Conclusions
We noted a dichotomous pattern of fecal colonization
with Gammaproteobacteria in our cohort of preterm in-
fants; some started with low relative abundance of Gam-
maproteobacteria and acquired those as a function of
postnatal age, whereas others carried these bacteria in
high abundance since the early postnatal period. The
predominance of a single variant of Klebsiella indicated
a common, possibly hospital-derived, source. Vaginal
birth and antenatal steroids were identified as major
determinants of stool-associated Gammaproteobacteria,
indicating that vertical, mother-to-infant transmission of
Gammaproteobacteria may contribute to intestinal dys-
biosis in some infants.
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